DK3116891T3 - Immunglobulinrensning ved hjælp af forrensningstrin - Google Patents
Immunglobulinrensning ved hjælp af forrensningstrin Download PDFInfo
- Publication number
- DK3116891T3 DK3116891T3 DK15708522.6T DK15708522T DK3116891T3 DK 3116891 T3 DK3116891 T3 DK 3116891T3 DK 15708522 T DK15708522 T DK 15708522T DK 3116891 T3 DK3116891 T3 DK 3116891T3
- Authority
- DK
- Denmark
- Prior art keywords
- purification
- immunoglobulin
- steps
- purification steps
- immunoglobulin purification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/26—Cation exchangers for chromatographic processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
- B01J41/20—Anion exchangers for chromatographic processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1400131A HUP1400131A1 (hu) | 2014-03-10 | 2014-03-10 | Immunoglobulin tisztítása elõtisztítási lépések alkalmazásával |
| HU1500053A HUP1500053A1 (hu) | 2015-02-09 | 2015-02-09 | Immunglobulin tisztítása elõtisztítási lépések alkalmazásával |
| PCT/EP2015/054862 WO2015135884A1 (en) | 2014-03-10 | 2015-03-09 | Immunoglobulin purification using pre-cleaning steps |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3116891T3 true DK3116891T3 (da) | 2020-05-04 |
Family
ID=89991731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15708522.6T DK3116891T3 (da) | 2014-03-10 | 2015-03-09 | Immunglobulinrensning ved hjælp af forrensningstrin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10487138B2 (da) |
| EP (2) | EP3116891B1 (da) |
| JP (1) | JP6293907B2 (da) |
| KR (1) | KR101921552B1 (da) |
| CN (1) | CN106103465B (da) |
| CA (1) | CA2930350C (da) |
| DK (1) | DK3116891T3 (da) |
| ES (1) | ES2784749T3 (da) |
| HR (1) | HRP20200711T1 (da) |
| HU (1) | HUE048782T2 (da) |
| LT (1) | LT3116891T (da) |
| PL (1) | PL3116891T3 (da) |
| PT (1) | PT3116891T (da) |
| SI (1) | SI3116891T1 (da) |
| WO (1) | WO2015135884A1 (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2784749T3 (es) | 2014-03-10 | 2020-09-30 | Richter Gedeon Nyrt | Purificación de inmunoglobulina con el uso de etapas de limpieza previa |
| GB2539420B (en) * | 2015-06-16 | 2021-01-13 | Cytiva Sweden Ab | Determination of chromatography conditions |
| JP6851109B2 (ja) * | 2016-06-16 | 2021-03-31 | Jsr株式会社 | 抗体を精製する方法及び担体を洗浄する方法 |
| EP3472177B1 (en) * | 2016-06-17 | 2024-08-14 | F. Hoffmann-La Roche AG | Purification of multispecific antibodies |
| WO2018051348A1 (en) * | 2016-09-14 | 2018-03-22 | Insight Biopharmaceutical Ltd. | Methods of purifying and qualifying antibodies |
| WO2018173075A1 (en) * | 2017-03-24 | 2018-09-27 | Council Of Scientific And Industrial Research | A process for the purification of recombinant antibody fragments |
| EP3672981A4 (en) | 2017-08-22 | 2021-09-15 | Biogen MA Inc. | PROCESSES FOR PURIFYING ANTIBODIES PRESENTING REDUCED AGGREGATES WITH HIGH MOLECULAR WEIGHT |
| KR20190047376A (ko) * | 2017-10-27 | 2019-05-08 | 주식회사 녹십자 | 개선된 면역글로불린의 정제방법 |
| CN111818980B (zh) * | 2018-03-08 | 2022-10-11 | 生物辐射实验室股份有限公司 | 阴离子交换-疏水混合模式色谱树脂 |
| CN111902720B (zh) | 2018-03-21 | 2025-02-07 | 沃特世科技公司 | 基于非抗体高亲和力的样品制备、吸附剂、装置和方法 |
| GB201805142D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| EP3823594B1 (en) * | 2018-07-19 | 2025-02-05 | Ichnos Sciences S.A. | Liquid antibody formulation |
| KR102209790B1 (ko) * | 2018-12-20 | 2021-02-01 | 에이치케이이노엔 주식회사 | 친화성 크로마토그래피를 이용한 백신용 바이러스 정제방법 |
| JP7241888B2 (ja) * | 2018-12-30 | 2023-03-17 | エフ． ホフマン－ラ ロシュ アーゲー | ｐＨ勾配ＳＰＲに基づく結合アッセイ |
| US12246267B2 (en) * | 2019-03-21 | 2025-03-11 | Agency For Science, Technology And Research | Method of capturing and/or purifying a target |
| HU231498B1 (hu) * | 2019-04-04 | 2024-05-28 | Richter Gedeon Nyrt | Immunglobulinok affinitás kromatográfiájának fejlesztése kötést megelőző flokkulálás alkalmazásával |
| CA3143169A1 (en) * | 2019-06-10 | 2020-12-17 | Takeda Pharmaceutical Company Limited | Antibody purification methods and compositions thereof |
| CN114040815B (zh) | 2019-09-05 | 2024-06-28 | 生物辐射实验室股份有限公司 | 阴离子交换-疏水混合模式色谱树脂 |
| JP2023526738A (ja) * | 2020-04-10 | 2023-06-23 | プラズマ テクノロジーズ エルエルシー | タンパク質の単純化した高効率単離のための組成物および方法 |
| CN113563469A (zh) * | 2020-04-28 | 2021-10-29 | 江苏中新医药有限公司 | 高回收率纯化阿达木单抗的方法 |
| EP4142905A4 (en) * | 2020-05-01 | 2024-11-13 | Kashiv Biosciences, LLC | IMPROVED PROTEIN PURIFICATION PROCESS |
| WO2021220251A1 (en) | 2020-05-01 | 2021-11-04 | Kashiv Biosciences, Llc | An improved process of purification of protein |
| CA3234496A1 (en) * | 2021-10-08 | 2023-04-13 | Kashiv Biosciences, Llc | Separation of pre-peak and post-peak in fusion protein sample by using size exclusion high performance liquid chromatography |
| CA3234491A1 (en) * | 2021-10-08 | 2023-04-13 | Kashiv Biosciences, Llc | Separation of pre-peak in fusion protein sample by using size exclusion high performance liquid chromatography |
| CN114133446A (zh) * | 2021-12-31 | 2022-03-04 | 方坦思(上海)生物医药有限公司 | 单克隆抗体的纯化方法 |
| CN115304673B (zh) * | 2022-06-24 | 2024-10-01 | 上海赛伦生物技术股份有限公司 | 一种马抗破伤风特异性免疫球蛋白F(ab’)2的纯化方法及其应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0368904A1 (en) * | 1987-07-16 | 1990-05-23 | Schering Corporation | Purification of gm-csf |
| CA1341235C (en) | 1987-07-24 | 2001-05-22 | Randy R. Robinson | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US4983722A (en) | 1988-06-08 | 1991-01-08 | Miles Inc. | Removal of protein A from antibody preparations |
| AU8001291A (en) | 1990-05-31 | 1991-12-31 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Method for purifying hiv reverse transcriptase |
| EP1681305A3 (en) | 1991-03-18 | 2008-02-27 | New York University | Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| DE122004000008I1 (de) | 1991-06-14 | 2005-06-09 | Genentech Inc | Humanisierter Heregulin Antikörper. |
| DE69303494T2 (de) | 1992-11-13 | 1997-01-16 | Idec Pharma Corp | Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma |
| US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| BRPI9707379C8 (pt) | 1996-02-09 | 2017-12-12 | Abbott Biotech Ltd | composições farmacêuticas compreendendo anticorpo humano recombinante geneticamente engenheirado, e anticorpo humano recombinante geneticamente engenheirado. |
| CN100480269C (zh) | 1997-04-07 | 2009-04-22 | 基因技术股份有限公司 | 抗-血管内皮生长因子的抗体 |
| WO2001015011A2 (en) | 1999-08-26 | 2001-03-01 | Symtec Limited | Methods and devices for selecting data files |
| PT2087908T (pt) | 2001-06-26 | 2018-07-16 | Amgen Inc | Anticorpos contra opgl |
| US20030040027A1 (en) * | 2001-08-16 | 2003-02-27 | Gerd Ritter | Method for determining protein component in a biological sample |
| DE10155984A1 (de) | 2001-11-15 | 2003-05-28 | Boehringer Ingelheim Pharma | Verfahren zur Reduktion des Liganden-leakage von Affinitätschromatographie-Matrices |
| HUE025101T2 (en) | 2002-04-26 | 2016-02-29 | Genentech Inc | Purification of proteins other than affinity purification |
| EP1601697B1 (en) | 2003-02-28 | 2007-05-30 | Lonza Biologics plc | Antibody purification by Protein A and ion exchange chromatography |
| US20060257972A1 (en) | 2003-03-31 | 2006-11-16 | Takashi Ishihara | Purification of human monoclonal antibody and human polyclonal antibody |
| HUE050171T2 (hu) | 2003-07-28 | 2020-11-30 | Genentech Inc | Protein-A kioldódásának csökkentése protein-A affinitáskromatográfia során |
| ME01198B (me) * | 2003-11-05 | 2013-03-20 | Ares Trading Sa | Prečišćavanje il-18 vezujućeg proteina |
| KR101150050B1 (ko) | 2004-02-27 | 2012-07-05 | 지이 헬스케어 바이오-사이언시스 에이비 | 항체 정제 방법 |
| KR20070072510A (ko) * | 2004-08-30 | 2007-07-04 | 론자 바이올로직스 피엘씨 | 항체 정제를 위한 친화도- 및 이온 교환- 크로마토그래피 |
| PT2215117E (pt) | 2007-10-30 | 2015-04-01 | Genentech Inc | Purificação de anticorpo por cromatografia de troca de catiões |
| US20110105725A1 (en) | 2008-05-15 | 2011-05-05 | Novo Nordisk A/S | Antibody purification process |
| TW201024318A (en) | 2008-10-20 | 2010-07-01 | Abbott Lab | Isolation and purification of antibodies using protein A affinity chromatography |
| WO2010071208A1 (ja) | 2008-12-19 | 2010-06-24 | 武田薬品工業株式会社 | 抗体の精製方法 |
| KR101498772B1 (ko) * | 2009-07-24 | 2015-03-04 | 에프. 호프만-라 로슈 아게 | 항체 생성의 최적화 방법 |
| EP2462157B1 (en) * | 2009-08-07 | 2020-06-17 | EMD Millipore Corporation | Methods for purifying a target protein from one or more impurities in a sample |
| KR101764449B1 (ko) * | 2009-09-01 | 2017-08-02 | 제넨테크, 인크. | 변형된 단백질 ａ 용리를 통한 증진된 단백질 정제 |
| EP2490780A4 (en) | 2009-10-20 | 2014-04-09 | Merck Sharp & Dohme | USE OF A MIXED MODE CHROMATOGRAPHY FOR THE DETECTION AND PURIFICATION OF BASIC ANTIBODY PRODUCTS |
| US20130116413A1 (en) | 2009-12-29 | 2013-05-09 | Dr. Reddy's Laboratories, Inc. | Purification of proteins |
| KR101976853B1 (ko) | 2010-05-25 | 2019-05-09 | 제넨테크, 인크. | 폴리펩티드의 정제 방법 |
| MX344268B (es) * | 2010-10-11 | 2016-12-09 | Abbvie Inc * | Proceso para purificacion de proteinas. |
| BR112014000630A2 (pt) * | 2011-07-11 | 2017-02-14 | Glenmark Pharmaceuticals Sa | anticorpo antagonista ou fragmento do mesmo que se liga a uma ox40 humana, epítopo sobre o domínio extracelular ox40 humano, ácido nucleíco isolado, vetor, célula hospedeira, método para produzir um anticorpo ou fragmento do mesmo, composição imunoconjugado, método para tratar um distúrbio mediado por ox40 em um indivíduo, uso de um anticorpo ou fragmento do mesmo, artigo de manufatura, kit e método para classificação in vitro |
| WO2013066707A1 (en) | 2011-10-31 | 2013-05-10 | Merck Sharp & Dohme Corp. | Chromatography process for resolving heterogeneous antibody aggregates |
| US20140301977A1 (en) | 2011-11-02 | 2014-10-09 | Genentech, Inc. | Overload and elute chromatography |
| KR20150027060A (ko) * | 2012-05-31 | 2015-03-11 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 다중 모드의 기능성들을 갖는 입자들로 면역글로불린 g 조제물들의 크로마토그래피 정제 |
| KR101941742B1 (ko) * | 2012-06-21 | 2019-01-23 | 신톤 바이오파머슈티칼즈 비.브이. | 항체의 정제 방법 |
| ES2784749T3 (es) | 2014-03-10 | 2020-09-30 | Richter Gedeon Nyrt | Purificación de inmunoglobulina con el uso de etapas de limpieza previa |
-
2015
- 2015-03-09 ES ES15708522T patent/ES2784749T3/es active Active
- 2015-03-09 JP JP2016544089A patent/JP6293907B2/ja active Active
- 2015-03-09 KR KR1020167022454A patent/KR101921552B1/ko active Active
- 2015-03-09 PL PL15708522T patent/PL3116891T3/pl unknown
- 2015-03-09 US US15/120,359 patent/US10487138B2/en active Active
- 2015-03-09 EP EP15708522.6A patent/EP3116891B1/en active Active
- 2015-03-09 SI SI201531188T patent/SI3116891T1/sl unknown
- 2015-03-09 CA CA2930350A patent/CA2930350C/en active Active
- 2015-03-09 PT PT157085226T patent/PT3116891T/pt unknown
- 2015-03-09 EP EP20155836.8A patent/EP3674310A1/en active Pending
- 2015-03-09 LT LTEP15708522.6T patent/LT3116891T/lt unknown
- 2015-03-09 DK DK15708522.6T patent/DK3116891T3/da active
- 2015-03-09 CN CN201580012972.5A patent/CN106103465B/zh active Active
- 2015-03-09 WO PCT/EP2015/054862 patent/WO2015135884A1/en active Application Filing
- 2015-03-09 HU HUE15708522A patent/HUE048782T2/hu unknown
-
2020
- 2020-05-04 HR HRP20200711TT patent/HRP20200711T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI3116891T1 (sl) | 2020-07-31 |
| JP2017507907A (ja) | 2017-03-23 |
| EP3116891A1 (en) | 2017-01-18 |
| US20170058019A1 (en) | 2017-03-02 |
| PL3116891T3 (pl) | 2020-07-27 |
| JP6293907B2 (ja) | 2018-03-14 |
| CA2930350C (en) | 2021-04-06 |
| LT3116891T (lt) | 2020-03-25 |
| HRP20200711T1 (hr) | 2020-07-24 |
| HUE048782T2 (hu) | 2020-08-28 |
| KR101921552B1 (ko) | 2018-11-23 |
| EP3116891B1 (en) | 2020-02-12 |
| PT3116891T (pt) | 2020-05-18 |
| KR20160124107A (ko) | 2016-10-26 |
| CN106103465B (zh) | 2021-01-08 |
| WO2015135884A1 (en) | 2015-09-17 |
| ES2784749T3 (es) | 2020-09-30 |
| US10487138B2 (en) | 2019-11-26 |
| EP3674310A1 (en) | 2020-07-01 |
| CA2930350A1 (en) | 2015-09-17 |
| CN106103465A (zh) | 2016-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3116891T3 (da) | Immunglobulinrensning ved hjælp af forrensningstrin | |
| NL301117I1 (nl) | trastuzumab deruxtecan | |
| DK3186376T3 (da) | Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet | |
| DK3556775T3 (da) | Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter | |
| DK3268390T3 (da) | Fremgangsmåder til oprensning af bispecifikke antistoffer | |
| DK3110988T3 (da) | Metoder til behandling af lithiumholdige materialer | |
| DK3180331T3 (da) | Polymorfer af selinexor | |
| DK3560954T3 (da) | Modificeret j-kæde | |
| DK3757214T3 (da) | Sammensætninger til modulering af sod-1-ekspression | |
| DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
| DK3113858T3 (da) | Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater | |
| DK3303618T3 (da) | Fremgangsmåder til prognose af prostatacancer | |
| BR112016021624A2 (pt) | indexação de locais baseada em polígono | |
| PT3215530T (pt) | Anticorpos de il-6 melhorados | |
| DK3124651T3 (da) | Indretning til fremstilling af organisk hydrid | |
| DK3393468T3 (da) | Fremgangsmåder til behandling af en immundefektsygdom | |
| CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
| DK3164716T3 (da) | Fremgangsmåde til diagnosticering af neurodegenerative sygdomme | |
| DK3125942T3 (da) | Forstøvning af immunoglobulin | |
| DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
| HUE042493T2 (hu) | Újfajta fuzionált imidazobenzotiazol vegyületek | |
| DK3430072T3 (da) | Fremgangsmåde til oprensning af poloxamerer | |
| DK3795591T5 (da) | Cys80-konjugerede immunoglobuliner | |
| ES1157711Y (es) | Filtro | |
| ITUB20155097A1 (it) | Anticorpi umanizzati anti-BAG3 |